Detalles de la búsqueda
1.
CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques.
AIDS
; 22(2): 185-92, 2008 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-18097220
2.
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.
J Acquir Immune Defic Syndr
; 46(1): 48-55, 2007 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17909315
3.
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
J Infect Dis
; 194(12): 1672-6, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17109338
Resultados
1 -
3
de 3
1
Próxima >
>>